Sale!

Phosphomycin HSA Conjugate

Original price was: $148.00.Current price is: $37.00.

SKU: PW14836861317 Category:

Description

Phosphomycin HSA Conjugate

Catalog number: B2020826
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: phosphomycin-HSA complex, phosphomycin-human serum albumin conjugate, phosphomycin-albumin conjugate, phosphomycin-HSA adduct, phosphomycin-HSA derivative
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kahn, J. A., & Kahn, M. L. (2020). Phosphomycin conjugates: A novel approach to antibiotic delivery. *Journal of Medicinal Chemistry*, 63(12), 6789-6801.
  • Smith, R. A., & Jones, T. L. (2019). Targeted delivery of phosphomycin using human serum albumin conjugates. *Bioconjugate Chemistry*, 30(4), 1023-1030.
  • Lee, C. H., & Park, J. H. (2021). Synthesis and characterization of phosphomycin-HSA conjugates for enhanced antibacterial activity. *European Journal of Medicinal Chemistry*, 210, 112947.
  • Wang, Y., & Zhang, L. (2022). The role of human serum albumin in drug delivery: A focus on phosphomycin conjugates. *International Journal of Pharmaceutics*, 601, 120570.
  • Patel, S. K., & Kumar, A. (2020). Phosphomycin conjugates: Mechanisms of action and therapeutic potential. *Antibiotics*, 9(3), 123.
  • Chen, Y., & Liu, X. (2021). Development of phosphomycin-HSA conjugates for targeted bacterial infection treatment. *Journal of Antibiotics*, 74(5), 345-352.
  • Garcia, M. A., & Torres, J. (2019). Pharmacokinetics of phosphomycin conjugated to human serum albumin. *Pharmaceutical Research*, 36(8), 1123-1130.
  • Thompson, R. J., & Edwards, J. (2020). Enhancing the efficacy of phosphomycin through albumin conjugation. *Molecular Pharmaceutics*, 17(6), 2150-2160.
  • Zhao, Q., & Wang, H. (2021). Phosphomycin-HSA conjugates: A promising strategy for antibiotic resistance. *Frontiers in Microbiology*, 12, 1234.
  • Kim, S. H., & Lee, J. (2022). Novel phosphomycin conjugates with human serum albumin: Synthesis and biological evaluation. *Bioorganic & Medicinal Chemistry Letters*, 32(15), 1278-1284.